TriangleDISEASE & TREATMENT SETTING
Uterine Neoplasm
Source-derived catalogue. This is not a treatment recommendation or a personalised trial match.
Exact scope
Uterine Neoplasm
- Source population
- Not part of this definition
- Disease extent
- Not part of this definition
- Treatment line
- Not part of this definition
- Stage
- Not part of this definition
- Resectability
- Not part of this definition
Biomarkers, prior therapy and derivation
- molecular
- prior therapy
- derivation status
- source-attested
- derivation note
- Added because the terminology and the registry both attest it: an NCIt neoplasm concept named by 3 acquired study condition(s). It is absent from the NCI treatment-topic directory, which is not an exhaustive cancer inventory.
- source wording
- Source null
Study evidence for this setting
Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma
Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma
Intravaginal Artesunate for the Treatment of HPV+ High Grade Cervical Intraepithelial Neoplasia (CIN2/3)
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
Basket Study of Tucatinib and Trastuzumab in Solid Tumors With HER2 Alterations
Source relationships and population-mapping limitations
- bindings
- release id
- clinical-indications-draft-1
- disease state id
- ds-uterine-neoplasm
- binding id
- ncit-C3435
- source collection
- ncit-concept
- source key
- C3435
- source excerpt
- Source null
- match status
- exact
- match note
- Source null
- recorded at
- 2026-09-10T00:00:00Z
- mappings
Download this complete draft source relationship record →
Preserved source evidence · Not medical advice